Iatrogenic Flecainide toxicityBOND, Richard; AUGUSTINE, Daniel; WALKER, Stuart et al.Heart (London 1996). 2010, Vol 96, Num 24, pp 2048-2049, issn 1355-6037, 2 p.Article

Effects of MiRPI and DPP6 β-subunits on the blockade induced by flecainide of K_v4.3/KChlP2 channelsRADICKE, S; VAQUERO, M; CABALLERO, R et al.British journal of pharmacology. 2008, Vol 154, Num 4, pp 774-786, issn 0007-1188, 13 p.Article

Intoxicación aguda por flecainida = Acute flecainide overdoseORTEGA, M. Cabrera; ABOY, J. Gell; DIAZ BERTO, E et al.Anales de pediatria (2003. Ed. impresa). 2011, Vol 74, Num 1, pp 56-58, issn 1695-4033, 3 p.Article

Class I antiarrhythmic drugs produced a spinal anesthetic effect in ratsHUANG, Kuo-Lun; CHU, Chin-Chen; CHENG, Kuang-I et al.Neuroscience letters. 2011, Vol 505, Num 2, pp 216-220, issn 0304-3940, 5 p.Article

Étude de l'usage de l'acétate de flécaïnide auprès des médecins généralistes et des cardiologues hospitaliers ou libéraux en France. OBEPINE : etude observationnelle des prescriptions de flécaïnide = Flecainide acetate utilisation review among general practitioners and hospital or office-based cardiologists in France. Obepine : observational study of flecainideLIARD, F; LE HEUZEY, J.-Y; JAILLON, P et al.Annales de cardiologie et d'angéiologie (Paris). 2006, Vol 55, Num 3, pp 113-122, issn 0003-3928, 10 p.Article

Simultaneous separation of 14 antiarrhythmic drugs and determination of mexiletine and flecainide by capillary zone electrophoresisPLETRAS, Rafal; KOWALCZUK, Dorota; HOPKALA, Hanna et al.Journal of AOAC International. 2007, Vol 90, Num 4, pp 977-986, issn 1060-3271, 10 p.Article

ST-Segment Elevation in a Patient Receiving FlecainideCHUNG-ESAKI, Hangyul; TABAS, Jeffrey; GOLDSCHLAGER, Nora et al.Archives of internal medicine (1960). 2011, Vol 171, Num 1, pp 11-13, issn 0003-9926, 3 p.Article

Cardioversion with flecainide in patients with atrial fibrillation of recent onsetGOY, J.-J; MAENDLY, R; GRBIC, M et al.European journal of clinical pharmacology. 1985, Vol 27, Num 6, pp 737-738, issn 0031-6970Article

CYP2D6 genotype affects age-related decline in flecainide clearance: a population pharmacokinetic analysisDOKI, Kosuke; HOMMA, Masato; KUGA, Keisuke et al.Pharmacogenetics and genomics (Print). 2012, Vol 22, Num 11, pp 777-783, issn 1744-6872, 7 p.Article

Flecainide versus vernakalant for conversion of recent-onset atrial fibrillationCONDE, Diego; COSTABEL, Juan Pablo; CARO, Milagros et al.International journal of cardiology. 2013, Vol 168, Num 3, pp 2423-2425, issn 0167-5273, 3 p.Article

Flecainide toxicity in a pediatric patient due to differences in pharmacy compoundingSAM WANG, George; THAM, Eric; MAES, Jody et al.International journal of cardiology. 2012, Vol 161, Num 3, pp 178-179, issn 0167-5273, 2 p.Article

A possible association between Takotsubo cardiomyopathy and treatment with flecainideGABRIEL, Laurence; CHENU, Patrick; GUEDES, Antoine et al.International journal of cardiology. 2011, Vol 147, Num 1, pp 173-175, issn 0167-5273, 3 p.Article

Liquid chromatographic determination of unbound flecainide in therapeutic drug monitoringKATORI, Kumi; HOMMA, Masato; KUGA, Keisuke et al.Journal of pharmaceutical and biomedical analysis. 2003, Vol 32, Num 2, pp 375-380, issn 0731-7085, 6 p.Article

Effects of CYP2D6 genotypes on age-related change of flecainide metabolism: involvement of CYP1 A2-mediated metabolismDOKI, Kosuke; HOMMA, Masato; KUGA, Keisuke et al.British journal of clinical pharmacology. 2009, Vol 68, Num 1, pp 89-96, issn 0306-5251, 8 p.Article

Flutter auriculaire avec réponse ventriculaire rapide (conduction auriculo-ventriculaire 1:1) lors d'un traitement par flécaïnide = ATRIAL FLUTTER WITH 1:1 ATRIOVENTRICULAR CONDUCTION CAUSED BY FLECAINIDEROBINET, S; MELON, P; PIERARD, L et al.RMLG. Revue médicale de Liège. 2007, Vol 62, Num 12, pp 701-703, issn 0370-629X, 3 p.Article

Differentiation of the electrophysiological effects on the atrial myocardium between the pure Na channel blocker, pilsicainide, and flecainideKANEMOTO, Masashi; SHIMIZU, Akihiko; MATSUZAKI, Masunori et al.Cardiovascular drugs and therapy. 2004, Vol 18, Num 4, pp 295-303, issn 0920-3206, 9 p.Article

Dramatic improvement of myotonia permanens with flecainide: a two-case report of a possible bench-to-bedside pharmacogenetics strategyDESAPHY, Jean-François; MODONI, Anna; LOMONACO, Mauro et al.European journal of clinical pharmacology. 2013, Vol 69, Num 4, pp 1037-1039, issn 0031-6970, 3 p.Article

Flecainide Acetate Acetic Acid SolvatesVELDRE, Kaspars; ACTINS, Andris; EGLITE, Zane et al.Journal of pharmaceutical sciences. 2011, Vol 100, Num 2, pp 604-611, issn 0022-3549, 8 p.Article

Therapeutic monitoring of class I antiarrhythmic agents using high-resolution electrocardiography instead of blood samplesSUTOVSKY, Igor; KATOH, Takao; TAKAYAMA, Hideo et al.Circulation journal. 2003, Vol 67, Num 3, pp 195-198, issn 1346-9843, 4 p.Article

Paranoid psychosis due to flecainide toxicity in malignant neuropathic painBENNETT, M. I.Pain (Amsterdam). 1997, Vol 70, Num 1, pp 93-94, issn 0304-3959Article

Successful extracorporeal life support in a case of severe flecainide intoxicationAUZINGER, Georg M; SCHEINKESTEL, Carlos D.Critical care medicine. 2001, Vol 29, Num 4, pp 887-890, issn 0090-3493Article

Flecainide overdose: Is cardiopulmonary support the treatment?YASUI, R. K; CULCLASURE, T. F; KAUFMAN, D et al.Annals of emergency medicine. 1997, Vol 29, Num 5, pp 680-682, issn 0196-0644Article

Survival in a case of life-threatening flecainide overdoseHANLEY, N. A; BOURKE, J. P; GASCOIGNE, A. D et al.Intensive care medicine (Print). 1998, Vol 24, Num 7, pp 740-742, issn 0342-4642Article

Rapid and inexpensive high-performance liquid chromatographic method for the quantification of flecainide in serumKRÄMER, B. K; MAYER, F; LIEBICH, H. M et al.Journal of chromatography. 1988, Vol 427, Num 2, pp 351-358, issn 0021-9673Article

Pharmacodynamics and side effects of flecainide acetateSALERNO, D. M; GRANRUD, G; SHARKEY, P et al.Clinical pharmacology and therapeutics. 1986, Vol 40, Num 1, pp 101-107, issn 0009-9236Article